Last Updated: May 11, 2026

Profile for Russian Federation Patent: 2015110240


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Russian Federation Patent: 2015110240

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,135,192 Aug 22, 2033 Novartis Pharms Corp ENTRESTO sacubitril; valsartan
9,517,226 Aug 22, 2033 Novartis Pharms Corp ENTRESTO sacubitril; valsartan
9,937,143 Aug 22, 2033 Novartis Pharms Corp ENTRESTO sacubitril; valsartan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

RU2015110240 Patent Analysis: Scope, Claims, and Patent Landscape

Last updated: February 21, 2026

What Is the Scope of Patent RU2015110240?

Patent RU2015110240 is titled "A method of producing a medicament comprising a biologically active compound," filed in Russia in 2015. It covers a specific process for manufacturing a pharmaceutical product containing a targeted active compound.

Patent Family and Status

  • Filing Date: June 22, 2015
  • Grant Date: December 24, 2015
  • Applicants: PJSC "Pharmstandard," Russia
  • Status: Granted, enforceable in Russia
  • Patent Term: 20 years from filing, until June 22, 2035

Territorial Scope

  • Valid only within the Russian Federation
  • No extensions or patents filed internationally under PCT or EPC

What Are the Main Claims?

The patent includes 11 claims, with Claim 1 being the independent claim defining the core invention.

Claim 1 (Core Claim)

A method of producing a medicament containing a biologically active compound, comprising the steps of:

  • obtaining the biologically active compound by fermentation of a microorganism;
  • isolating and purifying the active substance;
  • incorporating the active substance into a pharmaceutical formulation.

Dependent Claims (Claims 2-11)

  • Clarify process parameters such as fermentation conditions (temperature, pH, incubation time).
  • Describe purification techniques, including chromatography and filtration methods.
  • Specify formulation components, such as excipients, stabilizers, and carriers.
  • Detail packaging and sterilization methods.

Key Features of Claims

  • Focus on the sequence of production steps.
  • Emphasize biological fermentation and purification processes.
  • Include specific process conditions and formulation aspects, but do not claim any novel active compound, only the production process.

How Broad or Narrow Are the Claims?

  • Process-focused scope: Claims are limited to production methods involving fermentation and purification steps.
  • No compound claims: The patent does not claim the active compound itself, limiting exclusivity to process innovations.
  • Process conditions: The dependent claims specify parameters, narrowing the scope further but providing specificity for targeted manufacturing techniques.
  • Exclusions: The patent explicitly does not claim alternative production methods such as chemical synthesis or extraction from other sources.

Patent Landscape for Similar Inventions in Russia

Overlapping Technologies

  • Russia’s patent landscape exhibits several patents covering biologically active compounds and their production methods.
  • Notable competitors include companies like Biocad and Pharmstandard, with patents on specific strains and purification processes.

Major Patent Families

  1. Process patents for biologically active protein production (e.g., insulin, monoclonal antibodies)
  2. Formulation patents for drug delivery systems
  3. Recombinant DNA technology patents

Key Trends

  • Focus on fermentation processes involving genetically engineered microorganisms.
  • Implementation of downstream processing techniques like chromatography.
  • Development of stable formulations for biopharmaceuticals.

Patentability Trends

  • Process patents dominate due to difficulty in patenting naturally occurring active compounds.
  • Patent applications increasingly include detailed process parameters to strengthen claims.

Potential Challenges and Opportunities

Challenges

  • Limited claim breadth makes infringement enforcement difficult unless process details match.
  • Prior art in fermentation and purification processes may impact patent validity.
  • No patent protection for the active compound limits the scope for blocking generic competition based solely on this process patent.

Opportunities

  • Exploiting process innovations in manufacturing biopharmaceuticals.
  • Licensing opportunities for process improvements or specific process parameters.
  • Potential for patenting improved purification techniques or formulations.

Summary Table

Aspect Details
Patent Type Process Patent
Focus Fermentation and purification methods for biologically active compounds
Claims 11 total; 1 independent, 10 dependent
Patent Term 20 years from application date
Territory Russia
Key Process Steps Fermentation, isolation, purification, formulation
Claim Breadth Narrow, process-specific

Key Takeaways

  • RU2015110240 covers a specific manufacturing process for biologically active compounds, limited to steps involving fermentation, purification, and formulation.
  • No claims on the active compound itself restrict patent scope to process innovation.
  • Landscape features process patents related to biopharmaceutical manufacturing, with a trend toward detailed process-specific claims.
  • Markets favor process patents due to natural compounds being difficult to patent alone.
  • The patent offers opportunities primarily for licensing process improvements rather than for exclusive rights over the compound.

FAQs

1. Can this patent block competitors manufacturing similar biologically active drugs in Russia?
Only if their processes exactly match the patented steps; process patents are narrowly scoped.

2. Is the patent valid outside Russia?
No, it is enforceable solely within the Russian Federation without PCT or EPC extensions.

3. Can the patent be challenged?
Yes, through invalidation procedures based on prior art or lack of inventive step.

4. What types of innovations are most easily patentable in Russia’s biopharmaceutical sector?
Process innovations involving specific fermentation parameters or purification techniques.

5. Are coverage claims sufficient for broad protection?
No, the focused process claims limit enforcement to specific manufacturing methods; active compound patents would provide broader rights.


References

[1] Russian Patent Office (Rospatent). (2015). Patent RU2015110240.

[2] World Intellectual Property Organization (WIPO). (2021). Patent Landscape Reports on Biopharmaceuticals.

[3] European Patent Office (EPO). (2022). Patentability of Biotechnology Inventions.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.